Published On: Sun, Sep 11th, 2016

Phibro Animal Health Corp. (PAHC) Given a $23.00 Price Target at Morgan Stanley

Phibro Animal Health Corp. (NASDAQ:PAHC) has been given a $23.00 price target by research analysts at Morgan Stanley in a research report issued to clients and investors on Sunday. The brokerage currently has a a “sell” rating on the stock. Morgan Stanley’s target price would suggest a potential downside of 10.96% from the company’s current price.
A number of other research firms have also weighed in on PAHC. TheStreet lowered Phibro Animal Health Corp. from a “hold” rating to a “sell” rating in a research note on Thursday, June 9th. Zacks Investment Research lowered Phibro Animal Health Corp. from a “hold” rating to a “sell” rating in a research note on Tuesday, August 23rd. Credit Suisse Group AG reiterated a “buy” rating and issued a $29.00 target price on shares of Phibro Animal Health Corp. in a research note on Tuesday, August 30th. Finally, Guggenheim reiterated a “buy” rating and issued a $26.00 target price (down previously from $34.00) on shares of Phibro Animal Health Corp. in a research note on Friday, May 13th. Four research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $31.71.
Phibro Animal Health Corp. (NASDAQ:PAHC) traded down 1.49% during trading on Friday, reaching $25.83. 122,593 shares of the company’s stock traded hands. The company has a 50 day moving average of $21.94 and a 200 day moving average of $22.11. Phibro Animal Health Corp. has a one year low of $16.80 and a one year high of $37.27. The firm has a market cap of $1.02 billion, a price-to-earnings ratio of 12.48 and a beta of 1.38.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/10/phibro-animal-health-corp-pahc-given-a-23-00-price-target-at-morgan-stanley.html

Phibro Animal Health Corp. (NASDAQ:PAHC) last released its earnings results on Monday, August 29th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.02. Phibro Animal Health Corp. had a return on equity of 105.21% and a net margin of 11.02%. The business had revenue of $189.20 million for the quarter. During the same quarter in the previous year, the business earned $0.44 EPS. The business’s revenue for the quarter was up 2.3% on a year-over-year basis. Equities research analysts predict that Phibro Animal Health Corp. will post $1.41 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 28th. Shareholders of record on Wednesday, September 7th will be issued a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend is Friday, September 2nd. Phibro Animal Health Corp.’s dividend payout ratio is presently 19.42%.
A number of large investors have modified their holdings of PAHC. Acadian Asset Management increased its stake in Phibro Animal Health Corp. by 649.1% in the fourth quarter. Acadian Asset Management now owns 68,537 shares of the company’s stock worth $2,063,000 after buying an additional 59,388 shares during the period. Janus Capital Management increased its stake in Phibro Animal Health Corp. by 3.1% in the third quarter. Janus Capital Management now owns 313,668 shares of the company’s stock worth $9,921,000 after buying an additional 9,408 shares during the period. Schwab Charles Investment Management Inc. increased its stake in Phibro Animal Health Corp. by 0.8% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 253,738 shares of the company’s stock worth $7,646,000 after buying an additional 1,892 shares during the period. Foresters Investment Management Company Inc. increased its stake in Phibro Animal Health Corp. by 8.4% in the fourth quarter. Foresters Investment Management Company Inc. now owns 953,775 shares of the company’s stock worth $28,737,000 after buying an additional 74,100 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in Phibro Animal Health Corp. by 92.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 269,740 shares of the company’s stock worth $8,128,000 after buying an additional 129,660 shares during the period. 47.95% of the stock is owned by institutional investors and hedge funds.
About Phibro Animal Health Corp.
Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.

Receive News & Ratings for Phibro Animal Health Corp. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Phibro Animal Health Corp. and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>